Table 1 Characteristics of included studies
First author, year [reference] | Population | Number of subjects | Obese, n (%) | Overweight, n (%) | Male sex, % | Age, years | Disease duration, months | Therapy duration, months | CRP, mg/dl | ESR, mm/h |
|---|---|---|---|---|---|---|---|---|---|---|
Ajeganova, 2013 [33] | RA | 1333 | 211 (15.8) | 524 (39.3) | 30.8 | 64.6 | – | – | 0.4 | 13 |
Choe, 2014 [28] | RA | 568 | 108 (19.0) | – | 11.3 | 56.6 | 85.2 | – | 0.07 | 31.2 |
Di Minno, 2012 [3] | PsA | 270 | 111 (41.1) | – | 45.9 | 51.73 | 58.44 | 12 | 0.264 | 18.05 |
Di Minno, 2012 [6] | PsA | 90 | 29 (32.2) | – | 46.7 | 52.5 | 108.96 | 12 | 0.22 | 17.9 |
Di Minno, 2013 [15] | PsA | 270 | 135 (50) | – | 46 | 51.7 | 110.9 | 12 | 2.6 | 18.1 |
Di Minno, 2014 [5] | PsA | 76 | 44 (57.9) | – | 43.6 | 46.2 | 114 | 6 | 0.42 | 20.2 |
Eder, 2015 [19] | PsA | 557 | 197 (35.4) | 200 (35.9) | 58.7 | 52.1 | 138 | 12 | 1.49 | 20.3 |
Ellerby, 2014 [25] | RA | 233 | 57 (24.5) | – | 30.9 | 60.8 | 129.6 | 36 | – | – |
Gremese, 2013 [29] | RA | 641 | 66 (10.3) | 207 (32.3) | 18.7 | 52.1 | 100.8 | 12 | – | 35.9 |
Heimans, 2013 [27] | RA | 508 | 292 (57.5) | – | 32.6 | 54.7 | – | 12 | 2.06 | 35.7 |
Iannone, 2013 [17] | PsA | 135 | 45 (33.3) | 47 (34.8) | 50.4 | 53.2 | 120 | 42.6 | 1.5 | 25.6 |
Iannone, 2015 [26] | RA | 292 | 66 (22.6) | – | 14.8 | 57.9 | 146.4 | 12 | 2,2 | 37.4 |
Iervolino, 2012 [30] | PsA | 136 | 82 (60.3) | 50 (36.8) | 42.6 | 45.62 | 62.28 | 3 | 0.602 | 21.93 |
Klaasen, 2011 [31] | RA | 89 | 15 (16.9) | 66 (74.2) | 25.9 | 55.7 | 98.9 | 4 | 2.27 | 34.7 |
Rodrigues, 2014 [34] | RA | 317 | 73 (23.0) | – | – | – | – | 6 | – | – |
Sandberg, 2014 [18] | RA | 495 | 85 (17.2) | 170 (34.3) | 28.7 | – | 6 | 6 | – | – |
Westhoff, 2007 [32] | RA | 767 | 149 (19.4) | 315 (41.1) | 28.4 | 57.2 | 11.5 | 36 | 2.15 | – |